106 results on '"Michael Hecht"'
Search Results
2. Phenotypes of Vascular Aging
3. Changes in Peripheral Blood Pressure with Normal and Accelerated Aging
4. c. Cardiovascular Risk Prediction
5. Effect of exercise on functional capacity and body weight for people with hypertension, type 2 diabetes, or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis
6. N-Terminal Pro-Brain Type Natriuretic Peptide Predicts Cardiovascular Events Independently of Arterial Stiffness, Assessed By Carotid-to-Femoral Pulse Wave Velocity, in Apparently Healthy Subjects
7. Blood pressure responses to testosterone therapy are amplified by hematocrit levels in opioid-induced androgen deficiency: a double-blind, randomized, placebo-controlled trial
8. The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics
9. Improving the accuracy of blood pressure measuring devices in Australia: a modelled return on investment study
10. The Prevalence of Polyneuropathy in Type 2 Diabetes Subgroups Based on HOMA2 Indices of β-Cell Function and Insulin Sensitivity
11. Lenient rate control versus strict rate control for atrial fibrillation: a statistical analysis plan for the Danish Atrial Fibrillation (DanAF) randomized clinical trial
12. Plasma Galectin-4 Levels are Increased after Stroke in Mice and Humans
13. How Does Occupational Lifting Affect Ambulatory Blood Pressure, Relative Aerobic Workload and Level of Physical Activity?
14. Retinal microvascular markers in type 2 diabetes subphenotypes and latent autoimmune diabetes of adults
15. S-21-2: MAY MEASUREMENT MONTH IN NEPAL: FIVE-YEAR COMPARISON OF BLOOD PRESSURE SCREENING RESULTS IN 2017 - 2021
16. PS-BPC08-4: IMPACT OF TESTOSTERONE REPLACEMENT THERAPY ON 24-HOUR AMBULATORY BLOOD PRESSUR E MEASUREMENTS IN MALES WITH OPIOID-INDUCED ANDROGEN DEFICIENCY. A PLACEBO-CONTROLLED RCT
17. AW-AD-6: PREVALENCE OF VALIDATED BLOOD PRESSURE MEASURING DEVICES BEING SOLD BY AMAZON: 12-MONTH PROSPECTIVE ANALYSIS ACROSS 10 COUNTRIES
18. Factors associated with blood pressure control in patients with hypertension and HIV at a large urban HIV clinic in Uganda
19. The urgency to regulate validation of automated blood pressure measuring devices: a policy statement and call to action from the world hypertension league
20. Effects of adding exercise to usual care in patients with either hypertension, type 2 diabetes or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis
21. The influence of age and sex on the prognostic importance of traditional cardiovascular risk factors, selected circulating biomarkers and other markers of subclinical cardiovascular damage
22. Long-term Weight Loss in a Primary Care–Anchored eHealth Lifestyle Coaching Program: Randomized Controlled Trial
23. P05-15 Effects on heart rate, physical activity and ambulatory blood pressure from occupational physical activity with and without lifting among farmers in Denmark
24. Risk of cardiovascular events associated with pathophysiological phenotypes of type 2 diabetes
25. Long term Weight Loss in a Primary Care-Anchored eHealth Lifestyle Coaching Program in Denmark: Randomized Controlled Trial (Preprint)
26. Long term Weight Loss in a Primary Care-Anchored Human eHealth Lifestyle Coaching Program in Denmark: A Randomized Controlled Trial
27. Renal Artery Stenting in Consecutive High‐Risk Patients With Atherosclerotic Renovascular Disease: A Prospective 2‐Center Cohort Study
28. Emerging Authors Program for Global Cardiovascular Disease Research-A collaboration of the U.S. Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to save Lives, and the World Hypertension League
29. Perceptions of pharmacists on the quality of automated blood pressure devices: a national survey
30. Validation Status of Blood Pressure Measuring Devices Sold Globally
31. Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
32. Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT)
33. Serum Potassium and Mortality in High-Risk Patients: SPRINT
34. Evaluation of Cardiac Damage in Hypertension: Electrocardiography
35. Identification of Important Factors Affecting Use of Digital Individualised Coaching and Treatment of Type 2 Diabetes in General Practice: A Qualitative Feasibility Study
36. ANTIHYPERTENSIVE DRUG THERAPY IN NEPAL: FINDINGS FROM MAY MEASUREMENT MONTHS 2019
37. THE EFFECTS OF ADDING EXERCISE TO USUAL CARE ON BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION, TYPE II DIABETES MELLITUS, AND/OR CARDIOVASCULAR DISEASE (PRELIMINARY RESULT)
38. THE ASSOCIATION BETWEEN N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND CARDIOVASCULAR DISEASE IS CONDITIONED BY PRESENCE OF INCREASED ARTERIAL STIFFNESS
39. Lenient rate control versus strict rate control for atrial fibrillation: a protocol for the Danish Atrial Fibrillation (DanAF) randomised clinical trial
40. Treatment of Hypertension in the Metabolic Syndrome
41. Building research capacity within cardiovascular disease prevention and management in low‐ and middle‐income countries: A collaboration of the US Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension League
42. Clinical audit of adherence to hypertension treatment guideline and control rates in hospitals of different sizes in Thailand
43. Factors affecting the fruit and vegetable intake in Nepal and its association with history of self-reported major cardiovascular events
44. Coronary flow impairment in asymptomatic patients with early stage type-2 diabetes: Detection by FFRCT
45. Intensive blood pressure control appears to be effective and safe in patients with peripheral artery disease: the Systolic Blood Pressure Intervention Trial
46. Intensive vs. standard blood pressure control and vascular procedures: insights from the Systolic Blood Pressure Intervention Trial (SPRINT)
47. Optimización del desempeño del observador al medir la presión arterial en el consultorio: declaración de posición de la Comisión Lancet de Hipertensión
48. Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial
49. Mean dietary salt intake in Nepal: A population survey with 24‐hour urine collections
50. Adding exercise to usual care in patients with hypertension, type 2 diabetes mellitus and/or cardiovascular disease: a protocol for a systematic review with meta-analysis and trial sequential analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.